IGeneX testing for practitioners: how to order through Fullscript
Access IGeneX testing within Fullscript. Order infectious disease and tick-borne illness testing as part of your clinical workflow.

What is IGeneX
IGeneX is a clinical laboratory that specializes in infectious disease testing, with a focus on tick-borne illnesses and related pathogens.
The laboratory offers blood-based assays designed to measure antibodies, antigens, and molecular markers associated with infectious agents. Testing is ordered by licensed healthcare practitioners and is reviewed as part of their own clinical assessment and individualized care.
Quick overview
Founded: 1991
Specialty: Infectious disease and tick-borne illness testing
Use case: Integrative, functional, and primary care settings
Availability: U.S. and international
Support: Provider education, interpretation tools, and clinical resources
How IGeneX tests are used in clinical practice
IGeneX testing may be considered when additional biomarker data is needed related to infectious disease assessment.Â
Common clinical contexts include:
- Suspected tick-borne illness
- Persistent or unexplained symptoms
- Multi-system presentations
- Fatigue or low energy
- Neurological or musculoskeletal-related concerns
- Baseline infectious disease assessment and monitoring
IGeneX reports organize biomarker findings into structured categories intended to support clinical interpretation alongside the broader clinical context.
Infectious disease testing results should be interpreted alongside exposure history, symptoms, physical examination, and other clinical and laboratory findings.

Laboratory standards and technology
Types of IGeneX tests
IGeneX testing spans several clinical areas:
Tick-borne illness testing (e.g., Lyme disease-related panels)
Co-infection panels (e.g., Babesia, Bartonella, and related organisms)
Infectious disease antibody and PCR testing
Neurological and systemic infection-related markers
Frequently ordered IGeneX tests
Lyme Disease Immunoblot
A blood-based test that evaluates antibody responses associated with Lyme disease.
Often considered when assessing suspected tick-borne illness.
Tick-Borne Disease Panel
A panel that measures markers associated with multiple tick-borne pathogens.
Often considered when broader infectious assessment is needed.
Co-Infection Panels
Panels that measure markers associated with additional tick-borne organisms.
Often considered when assessing multi-pathogen exposure.
PCR-Based Infectious Panels
Tests that evaluate molecular markers associated with infectious agents.
Often considered when evaluating molecular markers associated with specific pathogens.
Infectious Disease Panels
Blood-based tests that evaluate markers associated with various infectious diseases, such as sexually transmitted diseases/infections (STDs), Epstein-Barr, or Hepatitis (A, B, or C).
Often considered when assessing exposure or infection-related patterns.
Results reflect markers associated with infectious agents and may not independently establish active infection; interpret alongside exposure history, symptoms, and other clinical findings.
Saliva Hormone Opendx Deluxe
Saliva-based panels that evaluate hormone markers, including cortisol.
Often considered when providers are assessing stress response, energy patterns, sleep, and hormone-related wellness trends.
Heavy Metals, 21 Toxic/16 Nutritional
A urine-based test that evaluates select heavy metal and nutritional markers.
Often considered when providers are assessing environmental exposure patterns and overall wellness trends.
IGeneX test selection and turnaround times
Turnaround times may vary and are not guaranteed*
Commonly used test | Specimen | Typical turnaround | |
|---|---|---|---|
| Suspected Lyme disease | Lyme Immunoblot | Blood | ~10-14 days |
| Tick-borne illness | Tick-Borne Panel | Blood | ~10-14 days |
| Co-infection assessment | Co-Infection Panels | Blood | ~10-14 days |
| Molecular marker testing | PCR Panels | Blood | ~10-14 days |
How IGeneX tests compare
Antibody testing vs. PCR testing
Antibody testing | PCR testing | |
|---|---|---|
| Focus | Immune response patterns | Molecular markers associated with pathogens |
| Method | Immunoassay-based | Molecular testing |
| Use pattern | Exposure/immune response | Molecular marker assessment |
| Output | Antibody patterns | Molecular marker results for practitioner review |
Why order IGeneX tests through Fullscript
Fullscript allows practitioners to incorporate Access Labs testing into an existing clinical workflow:
Streamline the lab ordering process within your existing clinical workflow
Send requisitions directly to patients
Review results alongside other patient data
Access pricing information prior to ordering
Manage follow-up workflows within a single system
How to order IGeneX tests
Create a Fullscript account
Add an IGeneX test to a patient plan and send
Patients receive instructions for payment, lab draw, and processing
Review results within your Fullscript dashboard
Frequently asked questions about IGeneX testing
Key takeaways
- IGeneX provides specialty testing focused on infectious disease and tick-borne illness
- Tests are designed to measure biomarkers associated with pathogens and immune response
- Reports are structured to organize biomarker findings for practitioner review
- Test selection is guided by clinical presentation and assessment goals
- Fullscript enables integration of testing into clinical workflows

Start ordering Access Labs tests
Create a Fullscript account to access IGeneX testing
This content is intended for licensed healthcare practitioners for educational purposes. IGeneX tests are laboratory tests ordered and interpreted by the practitioner as part of their own clinical assessment, alongside exposure history, symptoms, physical examination, and other clinical and laboratory findings. Antibody and molecular testing reflect immune response or the presence of biomarkers and may not independently establish active infection or confirm any disease. Fullscript does not interpret results or provide medical advice.